Award notice · Contracts Finder
Bleeding Disorders including Haemophilia B
Part of Bleeding Disorders including Haemophilia B.
NHS National Framework Agreement for the supply of products for the treatment of Bleeding Disorders including Haemophilia B. Period of framework agreement: 1 July 2022 to 30 June 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Total maximum framework agreement including extension options will be no more than 48 months
- Procurement
- Bleeding Disorders including Haemophilia B
- Buyer
- NHS England
- Published
- 20 Jul 2022
- Status
- complete
- CPV
- 33141530 — Blood coagulants
- Tender period
- — – 14 Feb 2022
Awards
Other notices in this procurement
FAQs about this notice
What type of notice is this?
This is a award notice published via Contracts Finder on 20 Jul 2022.
Which procurement does this notice belong to?
It is part of "Bleeding Disorders including Haemophilia B", published by NHS England.
Has this notice resulted in an award?
8 awards are recorded on this notice, including to Pfizer Ltd.
Get the full procurement picture
Enable turns the UK's public-contract data into pipeline intelligence for bid and capture teams. Talk to us about access, alerts and tailored market analysis.
Get in touch with Enable